The need to address the challenge of vagueness across several domains of applicability of ontology is gaining research attention. The presence of vagueness in knowledge represented with description logic impairs automating reasoning and inference making. The importance of reducing this vagueness in the formalization of medical knowledge representation is rising, considering the vulnerability of this domain to the expression of vague concepts or terms. This vagueness may be addressed from the perspective of ontology modeling language application such as ontology web language (OWL). Although several attempts have been made to tackle this problem in other disease prognoses such as diabetes and cardiovascular diseases, a similar effort is missing for breast cancer. Minimizing vagueness in breast cancer ontology is necessary to enhance automated reasoning and handle knowledge representation problems. This study proposes a framework for reducing vagueness in breast cancer ontology. The approach obtained breast cancer crisp ontology and applied fuzzy ontology elements based on the Fuzzy OWL2 model to formulate breast cancer fuzzy ontology. This was achieved by extending the elements of OWL2 (a more expressive version of OWL) with annotation properties to fuzzify the breast cancer crisp ontology. Results obtained showed a significant reduction of vagueness in the domain, yielding 0.38 for vagueness spread and 1.0 for vagueness explicitness. In addition, ontology metrics such as completeness, consistency, correctness and accuracy were also evaluated, and we obtained impressive performance. The implication of this result is the reduction of vagueness in breast cancer ontology, which provides increased computational reasoning support to applications using the ontology.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500271 | PMC |
http://dx.doi.org/10.1007/s00521-021-06517-2 | DOI Listing |
Cell Mol Biol Lett
January 2025
Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Arcavacata Di Rende, 87036, Cosenza, Italy.
Breast cancer is the most commonly diagnosed type of cancer and the leading cause of cancer-related death in women worldwide. Highly targeted therapies have been developed for different subtypes of breast cancer, including hormone receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-positive breast cancer. However, triple-negative breast cancer (TNBC) and metastatic breast cancer disease are primarily treated with chemotherapy, which improves disease-free and overall survival, but does not offer a curative solution for these aggressive forms of breast cancer.
View Article and Find Full Text PDFSci Rep
January 2025
Department of Genetics, The University of Alabama at Birmingham, Birmingham, AL, USA.
Nowadays, chemotherapy and immunotherapy remain the major treatment strategies for Triple-Negative Breast Cancer (TNBC). Identifying biomarkers to pre-select and subclassify TNBC patients with distinct chemotherapy responses is essential. In the current study, we performed an unbiased Reverse Phase Protein Array (RPPA) on TNBC cells treated with chemotherapy compounds and found a leading significant increase of phosphor-AURKA/B/C, AURKA, AURKB, and PLK1, which fall into the mitotic kinase group.
View Article and Find Full Text PDFSci Rep
January 2025
Chair of Obstetrics Development, Faculty of Health Sciences, Medical University of Lublin, Lublin, Poland.
The aim of the study is to analyze the relationship between personality traits of women with hereditary predisposition to breast/ovarian cancer and their obstetric history and cancer-preventive behaviors. A total of 357 women, participants of 'The National Program for Families With Genetic/Familial High Risk for Cancer', were included in the study. The Neo Five-Factor Inventory (NEO-FFI) and a standardized original questionnaire designed for the purpose of the study were used.
View Article and Find Full Text PDFSci Rep
January 2025
College of Information Science and Technology, Hainan Normal University, Haikou, 571158, China.
Breast cancer is one of the most aggressive types of cancer, and its early diagnosis is crucial for reducing mortality rates and ensuring timely treatment. Computer-aided diagnosis systems provide automated mammography image processing, interpretation, and grading. However, since the currently existing methods suffer from such issues as overfitting, lack of adaptability, and dependence on massive annotated datasets, the present work introduces a hybrid approach to enhance breast cancer classification accuracy.
View Article and Find Full Text PDFSci Rep
January 2025
Department of Thyroid and Breast Surgery, Liaoning Provincial People's Hospital, People's Hospital of China Medical University), Shenyang, China.
This study aimed to explore the diagnostic value of the two cytology techniques, including liquid-based cytology of mammary ductal lavage fluid and nipple discharge smear cytology, in the intraductal lesions in patients with pathological nipple discharge (PND). This retrospective analysis included 119 patients with PND who underwent surgical treatment. At the same time, they all underwent fiberoptic ductoscopy (FDS), nipple discharge smear cytology and liquid-based cytology of ductal lavage fluid before surgery.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!